HIGHLIGHTS
SUMMARY
Although not included in the World Health Organization (WHO) list of potential risk factors for osteoporosis, antipsychotic medication use has been previously related to lower BMD. While the majority of extant studies investigating the impact of antipsychotics on BMD are in patients with schizophrenia, other studies have explored the impact of antipsychotics on BMD in other patients groups such as those with bipolar disorder and autism. Participants who reported using antipsychotic medication at any assessment were included as an "antipsychotic user" (n=49; 32.6% men) and "antipsychotic non-users" were drawn from the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.